Study of Medication Experiences of Patients with Cutaneous Lupus

What we are studying

The purpose of this research study is to evaluate patients’ experiences with treatment for cutaneous lupus. Subjects come in for four office visits to determine their experiences.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 12+

Eligibility Criteria

  • Diagnosed with cutaneous lupus by a dermatologist
  • Cutaneous lupus can be treated with a topical corticosteroid or oral hydroxychloroquine

What is involved

  • 4 office visits
  • Clinical assessment of disease
  • Questionnaires


$25 for participation

Contact Information

Study Coordinator
Michael Farhangian

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.